Which molecular targets do the ezetimibe and simvastatin components of INEGY act on?

In INEGY, ezetimibe targets the sterol transporter Niemann-Pick C1-Like 1 (NPC1L1), while simvastatin, after conversion in the liver to its active β-hydroxyacid form, inhibits HMG-CoA reductase.